- Published at
- by gurufocus.com
mixed
mixed
BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd.
PR NewswireTEL AVIV, Israel, Nov. 21, 2024
”“ BioLineRx to receive $10 million upfront payment from Ayrmid Ltd. (parent company of Gamida Cell) plus up to